Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

China · Delayed Price · Currency is CNY

53.90

0.00 (0.00%)

At close: Oct 8, 2026

SHE:301617 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,492	1,465	1,328	1,025	798.47	524.37
Revenue Growth	8.20%	10.30%	29.53%	28.39%	52.27%	38.20%
Gross Profit	289.54	295.56	328.55	285.75	277.67	177.33
Operating Income	191.96	195.41	241.77	209.64	207.33	124.89
Net Income	170.84	172.29	212.84	182.1	176.32	103.29
Earnings Per Share	0.98	0.99	2.12	1.40	1.35	0.83
EPS Growth	-36.73%	-53.26%	52.03%	3.20%	63.88%	60.41%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
China	1,447	1,299	992.4	792.46	520.83
Overseas	17.25	29.27	32.75	6.01	3.54
Total	1,465	1,328	1,025	798.47	524.37

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	532.21	656.27	958.58	228.52	149.15	70.02
Total Debt	1.16	1.83	0.27	0.53	2.58	2.9
Net Cash (Debt)	531.05	654.43	958.31	227.99	146.57	67.12
Net Cash Growth	-37.32%	-31.71%	320.32%	55.55%	118.37%	-
Net Cash Per Share	3.06	3.77	9.56	1.75	1.12	0.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-46.08	-2.97	161.76	146.23	188.95	79.51
Capital Expenditures	-102.26	-85.1	-55.45	-66.98	-135.05	-67.93
Free Cash Flow	-148.34	-88.07	106.31	79.26	53.9	11.58
Free Cash Flow Growth	-	-	34.14%	47.04%	365.44%	4.51%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	19.40%	20.18%	24.74%	27.87%	34.78%	33.82%
Operating Margin	12.86%	13.34%	18.21%	20.45%	25.97%	23.82%
Pretax Margin	13.20%	13.38%	18.40%	20.28%	25.21%	22.44%
Profit Margin	11.45%	11.76%	16.03%	17.76%	22.08%	19.70%
FCF Margin	-9.94%	-6.01%	8.01%	7.73%	6.75%	2.21%

Dividends

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Dividend Per Share	0.200	0.308	0.355
Dividend Per Share Growth	-46.63%	-13.32%	-
Dividend Yield	0.37%	0.52%	1.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	54.78	60.32	24.74	-	-	-
Forward PE	-	43.09	-	-	-	-
P/FCF Ratio	-	-	49.53	-	-	-
PS Ratio	6.27	7.10	3.97	-	-	-